Physician profile
Daniel Wu
NPI 1811195498
$1,145.19
in general payments reported to CMS, 2019-2025
11 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $35.21 · 2023: $243 · 2024: $67.19 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $300.00 | 2019 | |
| Kci USA, INC. | $175.24 | 2019-2020 | |
| Smith+Nephew, INC. | $154.93 | 2024-2025 | Collagenase Santyl, Stravix, Stravix Pl |
| Aroa Biosurgery Incorporated | $145.00 | 2023 | |
| Haemonetics Corporation | $98.25 | 2023 | Teg6s Hemostasis System |
| Zimmer Biomet Holdings, INC. | $84.58 | 2019 | |
| Integra Lifesciences Corporation | $64.75 | 2019 | |
| Z-Medica, LLC | $51.09 | 2019 | |
| Ethicon US, LLC | $40.57 | 2024-2025 | Contour, Echelon Flex, Ethicon |
| Edwards Lifesciences Corporation | $17.56 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.